(Total Views: 85)
Posted On: 05/17/2023 10:10:48 AM
Post# of 21197
$IMMP News Article - Immutep's Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer https://marketwirenews.com/news-releases/immu...96473.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼